Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Managers say they support skills-based hiring. But many jobs still require 4-year degrees

Just over half of hiring managers say removing four-year degree requirements would positively impact their company's hiring practices, according to a OneTen report.

Fortune

Dow Jones Falls On Weak China Data; Oil Prices Jump On Extended Production Cuts

The Dow Jones dropped Tuesday amid weak economic data out of China. Tesla stock is in focus after strong monthly China sales.

Investors Business Daily

Dow Jones Rallies 250 Points On Unemployment Rate Jump; Tesla Stock Skids After New Model 3 Release

The Dow Jones rallied 250 points Friday on a jump in the unemployment rate. Tesla stock fell after the company released an updated Model 3 sedan.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Rallies 175 Points After Key Inflation Data; Palantir Dives On Downgrade

The Dow Jones Industrial Average rose 175 points Thursday after key inflation data. Palantir Technologies dived on an analyst downgrade.

Investors Business Daily

Dow Jones Erases Gains After Weak Jobs, GDP Data; Tesla Stock Slides On Sell Rating

The Dow Jones erased early gains Wednesday on weak jobs and GDP data. Tesla stock slid after Guggenheim kept its sell rating on the EV giant.

Investors Business Daily

Biden names 10 drugs for first negotiations to cut Medicare prices

Government claims prices could fall for 9m seniors but pharma companies claim cost-reduction program is unconstitutional

The Guardian - US

Biden targets diabetes drug Jardiance, blood thinner Eliquis, and 8 others for controversial Medicare price talks. But any relief is still years away

The move is expected to cut costs in a few years for some patients but faces litigation from the drugmakers and heavy criticism from Republican lawmakers.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Biden targets Jardiance, Eliquis and 8 other prescription drugs for Medicare price talks

President Joe Biden says for many Americans the cost of one drug can be “the difference between life and death” as his administration announces the first drugs that’ll be targeted for price negotiations in an effort to cut Medicare costs.

Chicago Sun-Times

The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List

Drugs from AbbVie, Bristol and Merck took slots on the list of drugs subject to price cuts. But the pharmaceutical stocks were unmoved.

Investors Business Daily

HHS lists first 10 drugs subject to Medicare price negotiation - Roll Call

The program is a major priority for Joe Biden, who ran for president in part on the promise to allow Medicare to negotiate drug prices.

Roll Call

Dow Jones Rises After Key Economic Data; Nio Dives, Pinduoduo Soars On Earnings

The Dow Jones Industrial Average rallied after key economic data Tuesday. Tesla stock rival Nio dived on earnings, while Pinduoduo soared.

Investors Business Daily

Dow Jones Futures Fall: Rally Attempt Continues As Nvidia Rebounds; Big Inflation, Jobs Data Due

Dow Jones futures: The stock market rally attempt continues, as Nvidia stock rebounds. Key jobs and inflation data is due this week.

Investors Business Daily

Dow Jones Rallies 300 Points With Jobs, Inflation Data On Deck; Tesla Rival Xpeng Surges On Didi Deal

The Dow Jones rallied 300 points Monday, as investors awaited this week's key jobs and inflation data. Tesla stock rival Xpeng surged.

Investors Business Daily

Dow Jones Reverses Lower As Powell Warns Of Higher Rates; Trump Returns To Twitter

The Dow Jones reversed lower Friday as Powell warned of higher rates. President Trump returned to X, formerly known as Twitter.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Falls After Surprise Jobless Claims; Nvidia Surges On Earnings

The Dow Jones dropped Thursday after a surprise drop in initial jobless claims. Nvidia surged on strong quarterly earnings results.

Investors Business Daily

Dow Jones Gains As Apple Stock Reboots; Michael Burry Unveils His New Big Short

The Dow Jones was firm as Apple stock rose. Big Short investor Michael Burry placed some new bets. Tesla stock fell on new price cuts.

Investors Business Daily

Top Biotech Roivant, Formed By Vivek Ramaswamy, Reports Steep Losses, Light Sales

Biotech stock Roivant — founded by presidential candidate Vivek Ramaswamy — reported steep losses and lighter sales.

Investors Business Daily

Mirati Rockets 33% On A Bevy Of News In Cancer, A $300 Million Deal And Its CEO Exit

A treatment regimen from Mirati handily beat Merck's blockbuster Keytruda in some lung cancer patients, and MRTX stock rocketed Wednesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Merck Stock Today: Why A Bear Call Spread Places $111 In Your Pocket Today

Selling a call spread out of the money in a sideways-to-downside formation has high probabilities of expiring worthless.

Barchart

3M vs. Merck: Which Dow Dividend Stock is a Better Buy?

MMM and MRK have both underperformed markets in 2023, but offer healthy yields for value-minded investors. Which of these dividend stocks is a better pick for your portfolio right now?

Investors Business Daily

Dow Jones Rises After Key Economic Data; Caterpillar, Merck, Uber Lead 9 Big Earnings Movers

The Dow Jones Industrial Average rose Tuesday after key economic data. Caterpillar, Merck and Uber were among nine big earnings movers.

Investors Business Daily

Merck Outplays The Covid Decline, But Prometheus Buyout Weighs On Profits

Merck topped second-quarter expectations Tuesday, though it reported a per-share loss. Merck stock toed the line in response.

The National (Scotland)

Jobs blow as science firm announces redundancies at Scottish plant

A SCOTTISH science and technology company has confirmed that "a small number" of employees are now facing redundancy.

Investors Business Daily

Roche Could Take A Page Out Of Merck's Playbook. Why Roivant Surged.

Roche is in discussions to buy a stomach-disease treatment from Roivant for around $7 billion. The report sent ROIV stock surging Friday.

Investors Business Daily

Dow Jones Rallies 275 Points On Cool Inflation Data; Nike Stock Slides On Earnings Miss

The Dow Jones Industrial Average rallied 275 points Friday on cool inflation data. Nike stock slid after missing Wall Street's earnings estimates.

1 … 9 10 11 12

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.